JavaScript is disabled for your browser. Some features of this site may not work without it.
Microbiocenosis of the Gastrointestinal Tract in Rheumatological Patients Taking NSAIDs
Marufkhanov Khamid Makhmudovich Doctor of Medical Sciences, Associate Professor of the Department of Propaedeutics of Internal Diseases No. 2, Tashkent Medical Academy, Tashkent, Uzbekistan Sibirkina Marina Valerievna Candidate of Medical Sciences, Associate Professor of the Department of Propaedeutics of Internal Diseases No. 2, Tashkent Medical Academy, Tashkent, Uzbekistan Eshmurzaeva Aida Abduganiyevna Candidate of Medical Sciences, Associate Professor of the Department of Propaedeutics of Internal Diseases No. 2, Tashkent Medical Academy, Tashkent, Uzbekistan Nurmetov Khabibullo Tulkinovich Candidate of Medical Sciences, Senior Lecturer of the Department of Propaedeutics of Internal Diseases No. 2, Tashkent Medical Academy, Tashkent, Uzbekistan
Modern rheumatology pays special attention to the detection of diseases at the earliest
possible stages. To date, there is evidence that the preclinical period of a systemic
autoimmune reaction is associated with dysregulation of immune interactions with
synanthropic microflora. The article deals with the issues of violation of the microbial
landscape in rheumatological patients and the impact on the microbiont of the stomach
and intestines of drugs used to treat rheumatological diseases
Imamova, Aqida(VI РЕСПУБЛИКАНСКАЯ НАУЧНО-ПРАКТИЧЕСКАЯ КОНФЕРЕНЦИЯ «СОВРЕМЕННЫЕ ДОСТИЖЕНИЯ И ПЕРСПЕКТИВЫ РАЗВИТИЯ ОХРАНЫ ЗДОРОВЬЯ НАСЕЛЕНИЯ» ПОСВЯЩЕННАЯ ВСЕМИРНОМУ ДНЮ ЗДОРОВЬЯ, 2024)
Esophageal cancer ranks the eighth in the world’s cancer incidence and the sixth in the global cancer death cause. There are two major histological subtypes of the esophagus: esophageal squamous cell carcinoma (ESCC) and ...